NVZMF (Novonesis (Novozymes) B) Cyclically Adjusted Book per Share: $12.16 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NVZMF Novonesis (Novozymes) B NVZMF
90 GF Score
Price $66.44
GF Value $63.82
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Novonesis (Novozymes) B Cyclically Adjusted Book per Share?

Novonesis (Novozymes) B NVZMF +2.08% 90 Cyclically Adjusted Book per Share is $12.16 as of Jun. 2026. GuruFocus rates NVZMF with a GF Score™ of 90/100 and a GF Value™ of $63.82 (Fairly Valued). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Novonesis (Novozymes) B's adjusted book value per share for the three months ended in Jun. 2026 was $27.353. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $12.16 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Novonesis (Novozymes) B's average Cyclically Adjusted Book Growth Rate was 25.00% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 15.00% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 11.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Novonesis (Novozymes) B was 15.00% per year. The lowest was 4.60% per year. And the median was 7.15% per year.

As of today (2026-09-22), Novonesis (Novozymes) B's current stock price is $66.4409. Novonesis (Novozymes) B's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 was $12.16. Novonesis (Novozymes) B's Cyclically Adjusted PB Ratio of today is 5.46.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Novonesis (Novozymes) B was 13.63. The lowest was 5.18. And the median was 9.17.


Novonesis (Novozymes) B  (OTCPK:NVZMF) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Novonesis (Novozymes) B's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=66.4409/12.163
=5.46

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Novonesis (Novozymes) B was 13.63. The lowest was 5.18. And the median was 9.17.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Novonesis (Novozymes) B Cyclically Adjusted Book per Share Related Terms


Novonesis (Novozymes) B Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Novonesis (Novozymes) B's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Novonesis (Novozymes) B Cyclically Adjusted Book per Share Chart

Novonesis (Novozymes) B Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.39 7.05 7.10 9.01 11.24

Novonesis (Novozymes) B Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.90 10.49 10.97 11.52 12.16

NVZMF vs LIN, SHW, ECL: Cyclically Adjusted Book per Share Comparison

For the Specialty Chemicals subindustry, Novonesis (Novozymes) B's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novonesis (Novozymes) B Cyclically Adjusted PB Ratio vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, Novonesis (Novozymes) B's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Novonesis (Novozymes) B's Cyclically Adjusted PB Ratio falls into.


NVZMF
90GF Score
Novonesis (Novozymes) B NVZMF
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Novonesis (Novozymes) B Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Novonesis (Novozymes) B's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book= Book Value per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=27.353/122.9500*122.9500
=27.353

Current CPI (Jun. 2026) = 122.9500.

Novonesis (Novozymes) B Quarterly Data

Book Value per Share CPI Adj_Book
201609 5.547 100.200 6.806
201612 5.598 100.300 6.862
201703 5.305 101.200 6.445
201706 5.548 101.200 6.740
201709 5.810 101.800 7.017
201712 6.203 101.300 7.529
201803 5.779 101.700 6.987
201806 5.784 102.300 6.952
201809 5.910 102.400 7.096
201812 6.092 102.100 7.336
201903 5.714 102.900 6.827
201906 5.893 102.900 7.041
201909 5.775 102.900 6.900
201912 6.130 102.900 7.324
202003 5.618 103.300 6.687
202006 5.816 103.200 6.929
202009 6.102 103.500 7.249
202012 6.617 103.400 7.868
202103 6.109 104.300 7.201
202106 6.273 105.000 7.345
202109 6.516 105.800 7.572
202112 6.735 106.600 7.768
202203 6.310 109.900 7.059
202206 6.356 113.600 6.879
202209 6.695 116.400 7.072
202212 7.382 115.900 7.831
202303 6.995 117.300 7.332
202306 7.298 116.400 7.709
202309 7.631 117.400 7.992
202312 7.668 116.700 8.079
202403 25.752 118.400 26.742
202406 25.386 118.500 26.339
202409 26.416 118.900 27.316
202412 24.827 118.900 25.673
202503 26.022 120.200 26.617
202506 27.085 120.700 27.590
202509 27.109 121.600 27.410
202512 27.363 121.180 27.763
202603 26.986 121.670 27.270
202606 27.353 122.950 27.353

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of $12.16 mean?
Novonesis (Novozymes) B (NVZMF) has a Cyclically Adjusted Book per Share of $12.16 as of Jun. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Novonesis (Novozymes) B and its competitors.
Is Novonesis (Novozymes) B's Cyclically Adjusted Book per Share too high?
Novonesis (Novozymes) B's current Cyclically Adjusted Book per Share is $12.16. Overall, Novonesis (Novozymes) B has a GF Score™ of 90/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Novonesis (Novozymes) B's Cyclically Adjusted Book per Share compare to LIN and SHW?
Novonesis (Novozymes) B's Cyclically Adjusted Book per Share of $12.16 can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Chemicals company?
A good Cyclically Adjusted Book per Share depends on the Chemicals industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Novonesis (Novozymes) B and its competitors. Novonesis (Novozymes) B's current Cyclically Adjusted Book per Share is $12.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Novonesis (Novozymes) B stock overvalued right now?
Based on GuruFocus' analysis, Novonesis (Novozymes) B (NVZMF) is currently considered Fairly Valued. The stock's GF Value™ is $63.82, compared to a current price of $66.44 — trading 4.1% above its estimated fair value. The current Cyclically Adjusted Book per Share is $12.16. Novonesis (Novozymes) B's overall GF Score™ is 90/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Novonesis (Novozymes) B (NVZMF), the current Cyclically Adjusted Book per Share is $12.16 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Novonesis (Novozymes) B (NVZMF) Overvalued in 2026?

Based on GuruFocus' analysis, Novonesis (Novozymes) B stock appears to be overvalued. The current stock price of $66.44 is trading 4.1% above its estimated GF Value™ of $63.82. GuruFocus considers Novonesis (Novozymes) B to be Fairly Valued.

Key valuation signals for NVZMF:

  • Cyclically Adjusted Book per Share: $12.16
  • GF Value™: $63.82 vs. price of $66.44 (4.1% above fair value)
  • GF Score™: 90/100 with 5 warning signs

No single metric tells the full story. See the NVZMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Novonesis (Novozymes) B Business Description

Address Krogshoejvej 36, Bagsvaerd, DNK, 2880
Novonesis (Novozymes) B is a Danish biotechnology company formed in 2024 through the merger of Novozymes and Chr. Hansen. It is a leading global producer of industrial enzymes and microbial solutions, serving industries such as household care, food and beverages, bioenergy, agriculture and animal feed, and technical and pharmaceutical applications. Its biological products help customers improve yield, efficiency, and performance while reducing energy use and waste. The company operates across two main business areas: enzymes and microorganisms, spanning food and health biosolutions and agriculture, bioenergy, and technical biosolutions. Headquartered in Denmark, Novonesis employs more than 11,000 people and operates numerous research, development, and application centers alongside manufacturing sites worldwide. Revenue is generated primarily through the sale of enzyme and microbial products to industrial and agricultural customers globally, supported by ongoing research and application development.
90GF Score

Get the complete analysis for NVZMF

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$66.44
Price
$63.82
GF Value